| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 44.71M | $149.79M | - | |
| 10% | 5.61M | $18.81M | - | |
| CEO | 832.6K | $2.79M | - | |
| Dir | 65.7K | $220.0K | - | |
| Dir | 55.3K | $185.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | Khurram Jamil | Chief Medical Officer | Sale+OE10b5-1 | 13,654 | $0.88 | $12,044.19 | -34.1% | +85.4% | +348.3% | |
| Dec 23, 2024 | Jack W Callicutt71 | Chief Financial Officer | Sale+OE10b5-1 | 40,000 | $0.89 | $35,492.00 | -84.0% | +85.4% | +348.3% | |
| Oct 23, 2024 | Kary Eldred81 | Director | Buy | 500 | $2.60 | $1,300.00 | +1.0% | -52.3% | +98.8% | |
| Oct 17, 2024 | Kevin D Freeman57 | Director | Buy | 1,300 | $2.64 | $3,432.00 | +3.9% | -51.9% | +87.6% | |
| Oct 16, 2024 | Kevin D Freeman57 | Director | Buy | 10,000 | $2.70 | $27,000.00 | +14.3% | -56.3% | +92.0% | |
| Aug 23, 2024 | Richard A. Zordani Jr.52 | Director | Buy | 3,500 | $2.30 | $8,050.00 | +12.2% | +17.7% | +77.5% | |
| Jun 20, 2024 | Kevin D Freeman57 | Director | Buy | 2,500 | $2.38 | $5,949.75 | +9.6% | +12.0% | 0.0% | |
| Apr 30, 2024 | Richard A. Zordani Jr.52 | Director | Buy | 1,000 | $3.52 | $3,520.00 | New | -26.8% | -61.0% | |
| Apr 24, 2024 | Joel Lewis67 | President and CEO | Buy | 1,000 | $3.39 | $3,390.00 | +100.0% | -21.3% | -56.8% | |
| Apr 23, 2024 | James C Czirr | 10% Owner | Sell | 25,000 | $3.06 | $76,500.00 | -0.4% | -26.6% | -60.4% |